The ORIGIN-FH Study
Key facts
- Where
- Madison, United StatesSee the site
Where in United States
- University of Wisconsin - MadisonMadison, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Wisconsin, Madison
- Trial code
- NCT07470723
- Record updated
- 13 October 2026
- Original description
The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will:Read full original descriptionShow less
Opportunity to Reach Individuals With Genetic Dyslipidemia During Infancy and the Newborn Period to Find Familial Hypercholesterolemia
The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will:
* undergo a cheek swab for genetic testing (parents only) * have 5 blood samples collected
Participants can expect to be in the trial for 2 years.
Inclusion: Individuals in the expectant partnership providing informed consent are at least 18 years of age; Ability to understand and willingness to sign a written informed consent document; Willingness to comply with all study procedures and be available for the duration of the study; Expectant parent (currently pregnant with fetus ≥12 weeks gestation) where one or both partners have been diagnosed with possible or definite HoFH or HeFH based on Dutch Lipid Clinic Network (DLCN) or confirmed diagnosis from a healthcare provider. At minimum, at least one parent with HoFH or HeFH must be willing to consent to study participation. However, both parents will be invited to participate; Parent(s) commit to using local laboratory services for infant blood samples, with mobile phlebotomy used as an alternative if available in their area; Newborn does not have any congenital abnormalities or medical conditions that may interfere with collection of dried blood spot (DBS) specimen and newborn does not require admission to neonatal intensive care unit.
Exclusion: Newborn has medical condition precluding DBS specimen collection, or a newborn's DBS specimen is not collected by 1 week of age; Expectant partnership where neither partner meets diagnostic criteria for HeFH or HoFH; Parent refuses consent for newborn's study participation; Not suitable for study participation due to other reasons at the discretion of the investigators; Parent and newborn live outside of the United States.